How is the Terns Pharmaceuticals Inc today?

The Terns Pharmaceuticals Inc today is trading in the green, up by 0.32% at 3.11.

How has Terns Pharmaceuticals Inc performed historically?

The Terns Pharmaceuticals Inc is currently trading up 0.32% on an intraday basis in the past week the index rose 2.98%. The index has been down -15.72% in the past quarter and fell -48.25% in the past year. You can view this in the overview section.

What is Terns Pharmaceuticals Inc Annual Net Profit?

Terns Pharmaceuticals Inc Annual Net Profit rose 1.5% in the last year to $88.85 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Terns Pharmaceuticals Inc Price to Earning Ratio?

Terns Pharmaceuticals Inc Price to Earning Ratio is -3.01, which is negative.

What is Terns Pharmaceuticals Inc Stock Price?

Terns Pharmaceuticals Inc Stock Price fell 48.25% and underperformed its sector by 103.72% in the past year.

What is Terns Pharmaceuticals Inc Quarterly Net profit?

Terns Pharmaceuticals Inc Quarterly Net profit fell 6.86% YoY to $23.91 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Terns Pharmaceuticals Inc Debt to Equity Ratio?

Terns Pharmaceuticals Inc Debt to Equity Ratio is zero as the company is debt-free.

What is Terns Pharmaceuticals Inc Return on Equity(ROE)?

Terns Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -29.56%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Terns Pharmaceuticals Inc Mutual Fund Holding?

Terns Pharmaceuticals Inc Mutual Fund Holding decreased by 3.8% in the last quarter to 27.01.

What is Terns Pharmaceuticals Inc Institutional Holding?

Terns Pharmaceuticals Inc Institutional Holding decreased by 0.39% in the last quarter to 96.67.

Terns Pharmaceuticals Inc XNAS: TERN

Terns Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Terns Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Terns Pharmaceuticals Inc
Rating: 1.35441675
Author: Trendlyne DVM scores

about

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chron...

3.11 0.01 (0.32%)

72.72% Fall from 52W High

730.9K XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Terns Pharmaceuticals Inc is on 11 Jun 2025 for the purpose of Terns Pharmaceuticals Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

12.2 / 100

Technically Neutral

42.0 / 100

No estimates available

Terns Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Terns Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chron...

72.72% Fall from 52W High

SWOT Analysis

Terns Pharmaceuticals Inc Live Price Chart

Terns Pharmaceuticals Inc FAQ

How is Terns Pharmaceuticals Inc today?

Terns Pharmaceuticals Inc today is trading in the green, and is up by 0.32% at 3.11.

How has Terns Pharmaceuticals Inc performed historically?

Terns Pharmaceuticals Inc is currently trading up 0.32% on an intraday basis. In the past week the stock rose 2.98%. stock has been down -15.72% in the past quarter and fell -48.25% in the past year. You can view this in the overview section.